Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA (ZX008) in Dravet Syndrome
pharmaceutical investing Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
Homerun Resources Inc. Announces Approval by ANM of Final Exploration Report for Mineral Rights Leased from CBPM in the Santa Maria Eterna High Purity Silica District